Table 3 Adverse events
PIB (n = 21) | CEI (n = 21) | P-value | |
|---|---|---|---|
n (%) | n (%) | ||
Adverse effects | |||
Nausea, vomiting | 8(38.1) | 5(23.8) | 0.32 |
Urinary retention | 2(9.5) | 3(14.3) | 0.63 |
Feeling dizzy on standing up | 4(19.0) | 1(4.7) | 0.15 |
PIB (n = 21) | CEI (n = 21) | P-value | |
|---|---|---|---|
n (%) | n (%) | ||
Adverse effects | |||
Nausea, vomiting | 8(38.1) | 5(23.8) | 0.32 |
Urinary retention | 2(9.5) | 3(14.3) | 0.63 |
Feeling dizzy on standing up | 4(19.0) | 1(4.7) | 0.15 |